1. Home
  2. NCEL vs DTSS Comparison

NCEL vs DTSS Comparison

Compare NCEL & DTSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NCEL

NewcelX Ltd. Ordinary Shares

N/A

Current Price

$2.64

Market Cap

12.0M

Sector

Health Care

ML Signal

N/A

Logo Datasea Inc.

DTSS

Datasea Inc.

HOLD

Current Price

$1.01

Market Cap

10.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NCEL
DTSS
Founded
2008
2014
Country
Switzerland
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
12.0M
10.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NCEL
DTSS
Price
$2.64
$1.01
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
186.8K
126.0K
Earning Date
12-01-2025
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$64,349,277.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
68.56
52 Week Low
$1.89
$0.64
52 Week High
$7.64
$2.89

Technical Indicators

Market Signals
Indicator
NCEL
DTSS
Relative Strength Index (RSI) 49.64 42.56
Support Level $2.40 $1.00
Resistance Level $2.86 $1.59
Average True Range (ATR) 0.24 0.19
MACD 0.04 -0.01
Stochastic Oscillator 38.55 10.94

Price Performance

Historical Comparison
NCEL
DTSS

About NCEL NewcelX Ltd. Ordinary Shares

NewcelX Ltd is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company's integrated platform combines advanced stem-cell technologies and neuroscience expertise to deliver scalable, regenerative treatments targeting conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. It has research and development operations in Ness Ziona, Israel.

About DTSS Datasea Inc.

Datasea Inc is a technology company that operates in two main segments. The first segment, Acoustic High-Tech, focuses on developing and applying acoustic technologies, such as ultrasound, infrasound, and mechanical wave effects, for applications like ultrasonic sterilization, neuro-regulation, acupoint stimulation, and environmental purification. The second segment, AI Multimodal Digitalization, integrates artificial intelligence with 5G networks and big data processing to create a proprietary multimodal data platform that combines text, voice, image, and video for real-time intelligent analysis and generation. The company generates all of its revenue from the People's Republic of China (PRC).

Share on Social Networks: